SkyePharma unveils new controlled release technology
SkyePharma used its latest business review meeting to announce the imminent arrival of a new rheumatoid arthritis (RA) drug formulated using its novel controlled release drug delivery technology.
Archives for June 25, 2006
Better relationship between wholesalers and manufacturers could cut costs
The traditional adversarial relationship of wholesalers with manufacturers must change to true partnership if both are to achieve better profits and secure the integrity of the drug supply chain, delegates of the annual general meeting of the European...
EntreMed encouraged by rheumatoid arthritis lead compound
EntreMed has produced hard data demonstrating antiangiogenic activity of its lead compound against the devastating effects of rheumatoid arthritis (RA). The results pave the way to developing therapeutics for the cancer and inflammatory treatment.
Toxic plant extracts form basis of stroke treatments
A toxic group of plant extracts has been found to protect animal tissue against the lack of blood that occurs in stroke giving rise to a new direction in the development of stroke treatment.
Drug firm marketing practices deceive consumers, claims report
A new report has blasted pharmaceutical companies for its use of unscrupulous marketing practices, accusing the drug producers of misleading physicians of a drug's effectiveness and convincing consumers of the drug's importance.
Valois uses Malvern's technology for novel nasal spray
UK-based Malvern Instruments has revealed that its next-generation particle size analysis system is being used by French contract manufacturer Valois in the validation of its unique nasal spray device.
Applied Biosystems shines a light on metabolite ID
Applied Biosystems (AB) has given drug researchers a new software application in thier quest to more quickly and accurately screen drug candidates, which can be further developed into promising new treatments.